Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgery Partners, Inc. - Common Stock (NQ: SGRY )

25.87 +0.08 (+0.31%)
Official Closing Price Updated: 4:15 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 911,925
Open 25.90
Bid (Size) 25.41 (1)
Ask (Size) 26.43 (1)
Prev. Close 25.79
Today's Range 25.77 - 26.16
52wk Range 19.50 - 34.67
Shares Outstanding 82,478,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
+21.51%
+21.51%
1 Month
+29.35%
+29.35%
3 Month
+18.51%
+18.51%
6 Month
-9.61%
-9.61%
1 Year
-24.42%
-24.42%

More News

Read More
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Via Benzinga
Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Key Takeaways From Surgery Partners Analyst Ratings
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Decoding 9 Analyst Evaluations For Surgery Partners
Via Benzinga
9 Analysts Assess Surgery Partners: What You Need To Know
Via Benzinga
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Via MarketBeat
Uncovering Noteworthy Technical Analysis Findings for SURGERY PARTNERS INC (NASDAQ:SGRY).
Via Chartmill
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What 8 Analyst Ratings Have To Say About Surgery Partners
Via Benzinga
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Via Benzinga
Expert Ratings For Surgery Partners
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Preview: Surgery Partners's Earnings
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 26, 2024
Via Benzinga
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Via Benzinga
Surgery Partners feeling no pinch from macroeconomic weakness
Via MarketBeat
Exposures COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.